TW223634B - - Google Patents

Info

Publication number
TW223634B
TW223634B TW080106545A TW80106545A TW223634B TW 223634 B TW223634 B TW 223634B TW 080106545 A TW080106545 A TW 080106545A TW 80106545 A TW80106545 A TW 80106545A TW 223634 B TW223634 B TW 223634B
Authority
TW
Taiwan
Prior art keywords
taxol
ring
preferred
derivative
contracted
Prior art date
Application number
TW080106545A
Other languages
English (en)
Chinese (zh)
Original Assignee
Kingston David G I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kingston David G I filed Critical Kingston David G I
Application granted granted Critical
Publication of TW223634B publication Critical patent/TW223634B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW080106545A 1991-03-18 1991-08-16 TW223634B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67043291A 1991-03-18 1991-03-18

Publications (1)

Publication Number Publication Date
TW223634B true TW223634B (enExample) 1994-05-11

Family

ID=24690379

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080106545A TW223634B (enExample) 1991-03-18 1991-08-16

Country Status (5)

Country Link
EP (1) EP0505047B1 (enExample)
JP (1) JPH0684364B2 (enExample)
AT (1) ATE137229T1 (enExample)
DE (1) DE69210078D1 (enExample)
TW (1) TW223634B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5553894A (en) * 1992-11-27 1994-06-22 F.H. Faulding & Co. Limited Injectable taxol composition
DE69333605T2 (de) * 1992-11-27 2005-02-03 Mayne Pharma (Usa) Inc. Stabile injizierbare Paclitaxel Lösung
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
GB9705903D0 (en) 1997-03-21 1997-05-07 Elliott Gillian D VP22 Proteins and uses thereof
WO2002024179A2 (en) 2000-09-22 2002-03-28 Bristol-Myers Squibb Company Method for reducing toxicity of combined chemotherapies
AU2002239282A1 (en) 2000-11-28 2002-06-11 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
RU2021128415A (ru) 2016-09-06 2021-11-08 Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч Композиции с паклитакселом, альбумином и связывающим средством и способы их применения и получения

Also Published As

Publication number Publication date
EP0505047A1 (en) 1992-09-23
EP0505047B1 (en) 1996-04-24
JPH0578342A (ja) 1993-03-30
DE69210078D1 (de) 1996-05-30
JPH0684364B2 (ja) 1994-10-26
ATE137229T1 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
DE3750612D1 (de) Cc-1065 analoge.
AU5754094A (en) Electrochemiluminescent assays
ES2071681T3 (es) Compuestos macrociclicos.
DE3576331D1 (de) Tetralin-derivate, ihre herstellung und verwendung.
DE69023934D1 (de) Substanz PF 1022, Verfahren zu ihrer Herstellung und diese Substanz enthaltende anthelmintische Zusammensetzung.
AU580973B2 (en) Novel polypeptides with an ``-amylase-inhibiting action, a process for their preparation, their use and pharmaceutical products
EP0690856A4 (enExample)
TW223634B (enExample)
ZA886820B (en) Steroids containing a spiro ring with 3,4 or 6 links in position 17,the process and intermediates for their preparation,their use as medicaments and the pharmaceutical compositions containing them
ATE137238T1 (de) Beta-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
IT8448702A0 (it) Impianto per la trasformazione biologica aerobica di materiali organici di rifiuto
ES2074148T3 (es) Nueva substancia anticancer antibiotica, su produccion y sus usos.
BR8705866A (pt) Processo para a preparacao de um isocianato epoxidado,produto obtido e composicao curavel
JPS55136261A (en) Novel compound and kit comprising it
JPS5659777A (en) Novel antibiotic, xk-213 and its preparation
ATE59635T1 (de) 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
IT1218557B (it) Processo per l'utilizzazione di materiali vegetali di scarto mediante fermentazioni aerobiche controllate precedute da pretrattamenti chimici
RU94027006A (ru) Способ получения 4-(гидроксиалкил)фенолов
ES2007239A6 (es) Sistema de reciclaje de purines.
GB2011410A (en) Pyrido[1,2-a]Pyrimidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them
DE3880348D1 (de) N-substituierte alpha-mercaptomethylbenzenpropanamid-derivate, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
NO902881D0 (no) Fremgangsmaate for fremstilling av en s-2,2-r1,r2-1,3-dioksolan-4-metanol.
Greenberger et al. Characterization of Bone Marrow Stromal Cells
HUT67254A (en) Process for the production of activ huric manure with biological, biochemical character, controlled by using anaerobe microbiological starterculture
SE8703641D0 (sv) Phosphorylated acylglycosides, their preparation and use